These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 25463026
1. Chronic intermittent hypoxia-induced neuronal apoptosis in the hippocampus is attenuated by telmisartan through suppression of iNOS/NO and inhibition of lipid peroxidation and inflammatory responses. Yuan X, Guo X, Deng Y, Zhu D, Shang J, Liu H. Brain Res; 2015 Jan 30; 1596():48-57. PubMed ID: 25463026 [Abstract] [Full Text] [Related]
2. Telmisartan attenuates myocardial apoptosis induced by chronic intermittent hypoxia in rats: modulation of nitric oxide metabolism and inflammatory mediators. Yuan X, Zhu D, Guo XL, Deng Y, Shang J, Liu K, Liu HG. Sleep Breath; 2015 May 30; 19(2):703-9. PubMed ID: 25413957 [Abstract] [Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Ibrahim MA, Ashour OM, Ibrahim YF, El-Bitar HI, Gomaa W, Abdel-Rahim SR. Pharmacol Res; 2009 Nov 30; 60(5):373-81. PubMed ID: 19467331 [Abstract] [Full Text] [Related]
4. Effect of Ca2EDTA on zinc mediated inflammation and neuronal apoptosis in hippocampus of an in vivo mouse model of hypobaric hypoxia. Malairaman U, Dandapani K, Katyal A. PLoS One; 2014 Nov 30; 9(10):e110253. PubMed ID: 25340757 [Abstract] [Full Text] [Related]
6. 1400W ameliorates acute hypobaric hypoxia/reoxygenation-induced cognitive deficits by suppressing the induction of inducible nitric oxide synthase in rat cerebral cortex microglia. Shi Q, Liu X, Wang N, Zheng X, Ran J, Liu Z, Fu J, Zheng J. Behav Brain Res; 2017 Feb 15; 319():188-199. PubMed ID: 27888018 [Abstract] [Full Text] [Related]
7. Effects of telmisartan, a unique angiotensin receptor blocker with selective peroxisome proliferator-activated receptor-gamma-modulating activity, on nitric oxide bioavailability and atherosclerotic change. Ikejima H, Imanishi T, Tsujioka H, Kuroi A, Kobayashi K, Shiomi M, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T. J Hypertens; 2008 May 15; 26(5):964-72. PubMed ID: 18398339 [Abstract] [Full Text] [Related]
8. Protective effect of telmisartan against cadmium-induced nephrotoxicity in mice. Fouad AA, Jresat I. Life Sci; 2011 Jul 04; 89(1-2):29-35. PubMed ID: 21620867 [Abstract] [Full Text] [Related]
14. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats. Kobayashi N, Ohno T, Yoshida K, Fukushima H, Mamada Y, Nomura M, Hirata H, Machida Y, Shinoda M, Suzuki N, Matsuoka H. Am J Hypertens; 2008 May 04; 21(5):576-81. PubMed ID: 18437150 [Abstract] [Full Text] [Related]
17. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan. Knorr M, Hausding M, Kröller-Schuhmacher S, Steven S, Oelze M, Heeren T, Scholz A, Gori T, Wenzel P, Schulz E, Daiber A, Münzel T. Arterioscler Thromb Vasc Biol; 2011 Oct 04; 31(10):2223-31. PubMed ID: 21757654 [Abstract] [Full Text] [Related]